Tuesday, September 15, 2015

Keep the Spotlight on Planned Parenthood

Stephen Heaney

Do not be distracted by misdirection. Do not let the horror of abortion be the main issue. Stick to the pertinent facts: Planned Parenthood is profiting from the sale of fetal parts. Planned Parenthood is routinely violating federal law. Planned Parenthood does not care about women.


In the second video, Mary Gatter, president of the Planned Parenthood Medical Directors’ Council, and medical director at Planned Parenthood Los Angeles until 2014, is clearly willing to accept, not what it would cost her clinic to process the fetal organs, but whatever the buyer is willing to pay. In the third video, Deborah Nucatola, senior director of medical services for PPFA, recognizes that the affiliates are looking for ways, not simply to break even, but to make a profit. In the fifth video, we see Abby Johnson, former director of Planned Parenthood Gulf Coast, testifying before the Senate Committee on Health and Human Services, that fetal specimens were bringing in up to $120,000 per month. “That is certainly not ‘recouping costs,’” she concludes.
In the fifth video, Melissa Farrell, current director of research at PP Gulf Coast, expresses her pride in how she contributes to the diversification of the revenue stream both locally and nationally. She talks about ways of “framing” compensation so that it does not look bad, especially if they are being paid more for tissue that is more difficult to obtain. If this were all just about recouping costs, there would be absolutely no reason to be looking for legal cover for their monetary gain.
The real kicker comes in the eighth video, where the CEO of StemExpress, Cate Dyer, explains why it is better for clinics to work with her company than rival Advanced BioScience Resources (ABR). ABR previously had a lock on the market because they had employees of their company on the advisory boards of Planned Parenthood affiliates. However, ABR, as a not-for-profit organization, was unwilling to pay as much as StemExpress, which was willing to give a kickback from their profits to the clinics.
In the ninth video, Perrin Larton, Procurement Manager for ABR, says that the company has people waiting right outside the operating room door to take the desired fetal tissue. If this is true, what possible cost could there be to be reimbursed? Any money received by a clinic under such circumstances is pure profit.

The whole thing is worth reading.
See also, On Abortion, Medical Science is Still Waiting to be Heard

No comments:

Post a Comment